DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES

MODULATOR ASSAY

VARIANT NUCLEIC ACID LIBRARIES FOR GLP1 RECEPTOR

Multispecific antibody comprising CD137 binding domain and PDL1 binding domain

NOVEL ANTI-PAD4 ANTIBODY

Anti-LY6H antibodies and antibody drug conjugates

Antibody binding specifically to CD40 and use thereof

Human antibodies to the human glucagon receptor (HGCGR) and methods of use thereof to lower blood glucose or ketone levels

ANTI-PD-L1/ANTI-B7-H3 MULTISPECIFIC ANTIBODIES AND USES THEREOF

ANTI-CTLA4 Antibodies, Antibody Fragments, Their Immunoconjugates and Uses Thereof

CD8 BINDING AGENTS AND USES THEREOF

NOVEL ANTI-CD3EPSILON ANTIBODIES

ANTI-ROR-2 ANTIBODIES AND METHODS OF USE

CD96-BINDING AGENTS AS IMMUNOMODULATORS

Humanized anti-CD3 antibodies, conjugates and uses thereof

CLAUDIN18.2 BINDING MOIETIES AND USES THEREOF

Antibody and use thereof

ANTIBODIES HAVING CONDITIONAL AFFINITY AND METHODS OF USE THEREOF

TAU BINDING COMPOUNDS

Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120

Anti-respiratory syncytial virus antibodies, and methods of their generation and use

ANTI-SARS-COV-2 SPIKE PROTEIN ANTIBODIES AND METHODS OF USE

SINGLE DOMAIN ANTIBODIES FOR SARS-COV-2

Anti-BK virus antibody molecules

ENGINEERED IMMUNE-MOBILIZING T-CELL RECEPTORS WITH ENHANCED AFFINITY FOR HIV-1 GAG

HUMAN IL-15 MUTANT AND USES THEREOF

ANTI-CD38 SINGLE-DOMAIN ANTIBODIES IN DISEASE MONITORING AND TREATMENT

ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF

LIQUID FORMULATION OF HUMANIZED ANTIBODY FOR TREATING IL-6-MEDIATED DISEASES

Synthetic Single Domain Library

RECOMBINANT HUMAN ANTIBODIES THAT INHIBIT THE HUMAN TISSUE KALLIKREIN 7 (KLK7) AND THEIR USE AGAINST DISEASES THAT CAUSE DESQUAMATION OF THE SKIN

Method for improving affinity of antibody for antigen and use thereof

Transferrin receptor (TFR)-selective binding peptides capable of crossing the blood brain barrier, encoding nucleic acids thereof and methods of use thereof

ANTI-NR10 ANTIBODY AND USE THEREOF

Antibody molecules and conjugates

Anti-CD11D antibodies and uses thereof

FC VARIANT AND PREPARATION THEREOF

ANTI-PD1 ANTIBODIES AND METHODS OF USE

ANTI-TIGIT ANTIBODY AND PREPARATION METHOD AND APPLICATION THEREOF

ANTI-CD96 ANTIBODIES AND METHODS OF USE THEREOF

FC-REGION VARIANTS WITH IMPROVED PROTEIN A-BINDING

ANTIBODIES BINDING TO CITRULLINATED HISTONE 2A AND/OR 4

MASK PEPTIDES AND MASKED ANTI-PTK7 ANTIBODIES COMPRISING SUCH

POLYPEPTIDES

Chimeric antigen receptors targeting FLT3

ANTI-LAMBDA MYELOMA ANTRIGEN (LMA) BINDING PROTEINS TO TREAT LMA-EXPRESSING CANCER AND AUTOIMMUNE DISORDERS

PROTEIN S ANTIBODIES, METHODS OF MAKING AND USES THEREOF

ANTI-CD25 ANTIBODIES, ANTIGEN-BINDING FRAGMENTS THEREOF, AND MEDICAL USES THEREOF

ANTIBODIES TO CARBOHYDRATE ANTIGENS

AGONISTIC TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY POLYPEPTIDES

FULLY HUMAN ANTI-HUMAN CD22 CHIMERIC ANTIGEN RECEPTOR AND APPLICATION THEREOF

Anti-TCR antibody molecules and uses thereof

SIRP ALPHA AND SIRP BETA 1 ANTIBODIES AND USES THEREOF

Antibodies Binding to ILT4

Compositions and Methods For Blood-Brain Barrier Delivery

ANTI-ACTH ANTIBODIES AND USE THEREOF

ANTI-BDNF ANTIBODIES AND METHODS OF USE THEREOF

SINGLE CHAIN ANTIBODIES AND INTRABODIES TO MISFOLDED TDP-43 AND METHODS OF USE

ANTI-NOVEL CORONAVIRUS MONOCLONAL ANTIBODY AND APPLICATION THEREOF

Collagen-localized immunomodulatory molecules and methods thereof

ANTIBODY-DRUG CONJUGATES

RECOMBINANT ANTIBODIES, KITS COMPRISING THE SAME, AND USES THEREOF

ANTI-PHENACETIN MONOCLONAL ANTIBODY HYBRIDOMA CELL STRAIN AD AND ITS PREPARATION METHOD AND APPLICATION

ANTI-TUMOR NECROSIS FACTOR RECEPTOR (TNFR2) ANTIBODIES AND USES THEREOF

METHODS OF ADMINISTERING ANTI-OX40 ANTIBODIES

ANTIBODY BINDING WITH SPECIFIC EPITOPE IN HUMAN IL-4R ALPHA AND APPLICATIONS OF ANTIBODY

ANTIBODY AND USES THEREOF

NOVEL ANTI-CTLA-4 ANTIBODY POLYPEPTIDE

TREM2 STABILIZING ANTIBODIES

ANTI-CSP ANTIBODIES

RED LIGHT-CONTROLLED PROTEIN DIMERIZATION SYSTEMS

BISPECIFIC ANTIBODIES FOR TREATING CD47-ASSOCIATED DISEASES

Anti-tissue factor antibodies, antibody-drug conjugates, and related methods

ANTI-CD73 ANTIBODY AND USE THEREOF

Anti-CD-25 antibody

AGENT, USES AND METHODS FOR TREATMENT

Anti-CD8 antibodies and uses thereof

EX VIVO GAMMA DELTA T CELL POPULATIONS

ANTIBODIES THAT BIND HUMAN CANNABINOID 1 (CB1) RECEPTOR

ANTI-G-CSF ANTIBODIES AND USES THEREOF

MODULAR SELF ASSEMBLY DISASSEMBLY (SADA) TECHNOLOGIES

Conjugates of Biomolecule and Use Thereof

ANIMAL MODELS AND THERAPEUTIC MOLECULES

ANTI-CD47 ANTIBODY AND USES THEREOF

Anti-OX40 antibody and uses thereof

CHEMOKINE RECEPTOR 4 (CXCR4) ANTAGONIST ANTIBODIES

ANTI-CD3-BINDING DOMAINS AND ANTIBODIES COMPRISING THEM, AND METHODS FOR THEIR GENERATION AND USE

ANTI-HUMAN NERVE GROWTH FACTOR ANTIBODY

Methods of using anti-PSGL-1 antibodies in combination with JAK inhibitors to treat T-cell mediated inflammatory diseases or cancers

HUMANIZED ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE (OACGD2)

Engineered Antibodies That Bind LAG3

BINDING MOLECULES TO CD38 AND PD-L1

BCMA BINDING MOLECULES AND METHODS OF USE THEREOF

SHEDDING BLOCKING AGENTS WITH INCREASED STABILITY

ANTI-PD1 ANTIBODIES AND METHODS OF USE

ANTI-PD-L1 ANTIBODY, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

COMPOSITIONS

AFFINITY MATURED AND HUMANIZED BINDING DOMAINS TARGETING ROR2

ANTIGEN-BINDING MOLECULE FOR PROMOTING DISAPPEARANCE OF ANTIGEN VIA Fc GAMMA RIIB

Anti-MUC1 antibody-drug conjugate

DEVELOPMENT AND APPLICATION OF IMMUNE CELL ACTIVATOR

Bispecific binding agents binding to CLDN18.2 and CD3

ANTIGEN BINDING PROTEINS

GLYPICAN-2-BINDING MOIETIES, CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD3

Method of treating an ocular condition by administering a humanized monoclonal antibodies that target VE-PTP (HPTP-Beta)

ANTI-TIGIT ANTIBODIES AND METHODS OF USE

ENGINEERED ANTIBODIES TO HIV ENV

CLDN18.2-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND USE THEREOF

TRANSGENIC MICE

Factor XI A2 domain-binding antibodies and methods of use thereof

Fusion proteins of GDF15 and use thereof

BISPECIFIC COMBINATION THERAPY FOR TREATING PROLIFERATIVE DISEASES AND AUTOIMMUNE DISEASES

PROTEINS SPECIFIC FOR BAFF AND B7RP1 AND USES THEREOF

MONOCLONAL ANTIBODIES TARGETING HSP70 AND THERAPEUTIC USES THEREOF

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CANINES AND METHODS OF USE

ANTIBODIES AGAINST PD-L1 AND METHODS OF USE THEREOF

Tau immunotherapy

ANTI-PACAP ANTIBODIES AND USES THEREOF

Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding Fragments

MULTISPECIFIC ANTI-CLAUDIN-18.2 CONSTRUCTS AND USES THEREOF

Antigen Binding Molecules comprising a TNF family ligand trimer and PD1 binding moiety

IMMUNOCONJUGATES AND METHODS

Anti-TREM1 antibodies and methods of use thereof

CD3 ANTIGEN BINDING FRAGMENTS AND COMPOSITIONS COMPRISING SAME

NEW POLYPEPTIDE COMPLEX

Tetravalent FZD and WNT Co-receptor Binding Molecules and Uses Thereof

Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

Bispecific antigen binding constructs targeting HER2

ANTI-HLA-DQ2.5 ANTIBODY

MUSCLE-TARGETING COMPLEXES AND USES THEREOF IN TREATING MUSCLE ATROPHY

ANTI-ACINETOBACTER BAUMANNII POLYCLONAL ANTIBODY (AB-pAb), AND USES THEREOF

Antagonist antibodies against human immune checkpoint CEACAM1 (CD66a) and formulations, kits, and methods of use thereof

SARS-COV-2 SPIKE PROTEIN ANTIBODIES

Recombinant fusion proteins targeting CD47 and CD24, preparation and use thereof

BINDING MOLECULE HAVING NEUTRALIZING ACTIVITY AGAINST SARS-CORONAVIRUS-2

GUIDANCE AND NAVIGATION CONTROL (GNC) ANTIBODY-LIKE PROTEINSAND METHODS OF MAKING AND USING THEREOF

Neutralizing anti-influenza binding molecules and uses thereof

MONOCLONAL ANTIBODY

Antibodies binding CD70, preparation and use thereof

ANTI-avB8 INTEGRIN ANTIBODIES FOR USE IN TREATING KIDNEY DISEASE

Human monocarboxylate transporter 1 antibodies and uses thereof

ANTI-CLEC12A ANTIBODIES AND USES THEREOF

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR MODULATION OF GENES ASSOCIATED WITH MUSCLE HEALTH

ANTI-CD276 POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS

Antibodies binding CD24, preparation and use thereof

Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

ANTI-NGF ANTIBODY AND ANTIGEN-BINDING FRAGMENT THEREOF, PREPARATION METHOD, AND APPLICATION THEREOF

TRBC BETA ANTIBODY CONJUGATE

METHODS OF ADMINISTERING ANTI-OX40 ANTIBODIES

ANTI-PD-1 ANTIBODIES AND METHODS OF USE

POLYPEPTIDE VARIANTS AND USES THEREOF

Antibodies binding Siglec15 and uses thereof

SIRPALPHA-TARGETING ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF, AND PREPARATION AND APPLICATION THEREOF

ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS

ANTI-TIM-3 ANTIBODIES AND COMPOSITIONS

ANTIBODY THAT BINDS TO VEGF AND PDGF-B AND METHODS OF USE

Antibody specific to spike protein of SARS-CoV-2 and uses thereof

ANTI-TRANSFERRIN RECEPTOR (TFR) ANTIBODY AND USES THEREOF

CD38 MODULATING ANTIBODY AGENTS

SPLIT CH2 DOMAINS

HUMAN-LIKE HEAVY CHAIN ANTIBODY VARIABLE DOMAIN (VHH) DISPLAY LIBRARIES

RESTORATION OF T CELL ACTIVITY VIA THE CD39/CD73 AXIS

VARIANT NUCLEIC ACID LIBRARIES FOR ANTIBODY OPTIMIZATION

ANTI-IDIOTYPIC ANTIBODIES AGAINST ANTI-CD79B ANTIBODIES

HIGH AFFINITY ANTIBODIES TO HUMAN IL-6 RECEPTOR

FUSION PROTEINS AND USES THEREOF

Antigen binding proteins specifically binding PRAME

METHOD FOR IMPROVING AFFINITY OF ANTI-CYTOKINE ANTIBODY FOR ANTIGEN, METHOD FOR PRODUCING ANTI-CYTOKINE ANTIBODY, AND ANTI-CYTOKINE ANTIBODY

Methods for treating hypertension using an anti-BMP10 monoclonal antibody or fragment thereof

Therapeutic Anti-IgE Antibodies and Methods and Compositions Thereof

HUMANIZED MONOCLONAL ANTIBODY AGAINST cANGPTL4

ANTI-CD47/ANTI-PD-L1 ANTIBODY AND APPLICATIONS THEREOF

MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137

ANTI-IL-22R ANTIBODIES

FUSION PROTEINS FOR SELECTIVELY DEPLETING ANTIGEN-SPECIFIC ANTIBODIES

Leucine-Rich Repeat Kinase 2 Allosteric Modulators

ANTI-PD-L1 ANTIBODIES

HUMAN CD47-TARGETING SINGLE-DOMAIN ANTIBODY AND USE THEREOF

ANTI-CD19 ANTIBODIES AND METHODS OF USING AND MAKING THEREOF

COMBINATION THERAPY USING ANTIBODY TO HUMAN SIGLEC-9 AND ANTIBODY TO HUMAN NKG2A FOR TREATING CANCER

DESIGN AND DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OFF-TARGET EFFECTS

Engineered anti-il-2 antibodies

Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof

PROTEIN S ANTIBODIES, METHODS OF MAKING AND USES THEREOF

ANTI D-DIMER RECOMBINANT ANTIBODIES, METHODS AND USES THEREOF

CD3 BINDING ANTIBODIES

ANTI-IL1RAP ANTIBODIES

ALPHA-SYNUCLEIN PROTOFIBRIL-BINDING ANTIBODIES

Anti-O2 antibodies and uses thereof

ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-MULLERIAN HORMONE RECEPTOR 2 ANTIBODIES AND METHODS OF USE

Antibodies to TGF-Beta

Fc variant with enhanced affinity to Fc receptors and improved thermal stability

Tetravalent bispecific antibody against PD-1 and PD-L1

ANTIBODIES AGAINST KLK5

OPTIMIZED ANTI-CD3 ARM IN THE GENERATION OF T-CELL BISPECIFIC ANTIBODIES FOR IMMUNOTHERAPY

Anti-FcRn Antibodies

Monospecific and bispecific antibodies and antigen binding fragments thereof

HUMAN HENDRA VIRUS AND NIPAH VIRUS ANTIBODIES AND METHODS OF USE THEREFOR

MULTISPECIFIC ANTIBODIES, COMPOSITIONS COMPRISING THE SAME, AND VECTORS AND USES THEREOF

Human monoclonal antibodies against yellow fever virus and uses therefor

PH-SENSITIVE FC VARIANTS

ANTIBODIES AGAINST KLK5

ANTI-PD-L1 ANTIBODIES

MULTISPECIFIC ANTIBODIES

NOVEL LILRB2 ANTIBODIES AND USES THEREOF

Anti-CD300F antibody and uses thereof

Glycosylated Single Chain Immunoglobulin Domains

ANTIBODY FC VARIANTS FOR INCREASED BLOOD HALF-LIFE

ANTI-BCMA HEAVY CHAIN-ONLY ANTIBODIES

Anti-CD30L antibodies and uses thereof

SERUM ALBUMIN BINDERS

ANTI-TIGIT ANTIBODIES, MULTISPECIFIC ANTIBODIES COMPRISING THE SAME, AND METHODS OF USING THE SAME

Antibodies specific for FLT3 and their uses

ANTI-CTLA-4 ANTIBODY AND USE THEREOF

MULTIMERIC CORONAVIRUS BINDING MOLECULES AND USES THEREOF

LONG LIFE POLYPEPTIDE BINDING MOLECULES

ANTI-IL-1-BETA ANTIBODIES

Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF-LIFE

Polynucleotides encoding, and method of making, a polypeptide comprising a VHH which binds interleukin-receptor (IL-7R)

Multi-specific antigen binding molecules targeting HIV and methods of use

ANTIBODIES BINDING BCMA AND USES THEREOF

V-C-FC-V-C ANTIBODY

ANTI-GALECTIN-9 ANTIBODY AND USES THEREOF

Anti-CD47 antibody and uses thereof

ANTI-PROPERDIN ANTIBODIES AND PREPARATION THEREOF

NOVEL ANTI-FGFR2B ANTIBODIES

ANTIBODY CONSTRUCTS BINDING 4-1BB AND TUMOR-ASSOCIATED ANTIGENS AND USES THEREOF

NOVEL ANTI-FGFR2B ANTIBODIES

Anti-transferrin receptor antibody and uses thereof

Multivalent D-Peptidic Compounds for Target Proteins

Anti-C1s antibodies and uses thereof

CXCL10 binding proteins and compositions thereof

CONFORMATION-SPECIFIC EPITOPES IN ALPHA-SYNUCLEIN, ANTIBODIES THERETO AND METHODS RELATED THEREOF

ANTI-BCMA/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF

CHIMERIC ANTIGEN RECEPTORS WITH CD28 MUTATIONS AND USE THEREOF

Anti-TIGIT Antibodies

Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness

Anti-C-C motif chemokine receptor 8 (CCR8) antibodies and methods of use

METHODS OF TREATING WARM AUTOIMMUNE HEMOLYTIC ANEMIA USING ANTI-FCRN ANTIBODIES

Structures for Reducing Antibody-Lipase Binding

CONSTRUCTS SPECIFICALLY RECOGNIZING GLYPICAN 3 AND USES THEREOF

ANTI-SORTILIN ANTIBODIES AND METHODS OF USE THEREOF

Nucleic acids encoding CX3CR1-binding polypeptides comprising immunoglobulin single variable domains

Chemically Induced Association and Dissociation of Therapeutic FC Compositions and Chemically Induced Dimerization of T Cell Engager with Human Serum Albumin

COMPOSITIONS AND METHODS FOR MAKING ANTIBODY CONJUGATES

ANTI-TNFR2 ANTIBODY AND USES THEREOF

TCR-LIKE ANTIBODY SPECIFIC TO CMV PP65 PEPTIDE/HLA-A*02 COMPLEX, AND USE THEREOF

Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy

ANTI-BCMA HEAVY CHAIN-ONLY ANTIBODIES

Anti-transferrin receptor (TFR) antibody and uses thereof

METHODS OF TREATING PREGNANCY-ASSOCIATED ATYPICAL HEMOLYTIC UREMIC SYNDROME USING AN ANTI-C5 ANTIBODY

ANTI-C5 ANTIBODY FOR THE TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDER

NOVEL METHODS OF GENERATING ANTIBODIES

ANTI-IL-27 ANTIBODIES AND USES THEREOF

Bispecific antibody constructs for CDH3 and CD3

Chimeric antigen receptors targeting CD70

Anti-HER2 Antibodies and Immunoconjugates

ANTIBODIES AGAINST AREG AND ITS USE

EXPRESSION OF SEQUENCE-ENGINEERED LAMBDA ANTIBODY LIGHT CHAINS

IGFBP3 ANTIBODIES AND THERAPEUTIC USES THEREOF

MULTISPECIFIC NANOBODIES CHIMERIC ANTIGEN RECEPTOR AND T-CELL ENGAGER, NUCLEIC ACID, EXPRESSING CELL THEREOF, PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, AND METHOD FOR INHIBITING PROLIFERATION OF TUMOR CELL

Human monoclonal antibody binding specifically to human HMGB1, and pharmaceutical composition for treating or preventing Alzheimer's disease containing said human monoclonal antibody

ANTI-TIGIT ANTIBODIES, MULTISPECIFIC ANTIBODIES COMPRISING THE SAME, AND METHODS OF USING THE SAME

ANTI-CD19 ANTIBODIES AND MULTI-SPECIFIC BINDING PROTEINS

BINDING MOLECULES AGAINST CD3 AND USES THEREOF

Anti-CD38 antibodies

ANTI-GDF15 ANTIBODY

TREATMENT OF CANCER COMPRISING ADMINISTRATION OF Vg9Vd2 T CELL RECEPTOR BINDING ANTIBODIES

PD-1 binding domains

Antigen binding molecules that bind LIGHT

ANTIBODY AGAINST HUMAN CYTOMEGALOVIRUS AND USE THEREOF

ANTIBODIES BINDING RANKL AND USES THEREOF

Novel Molecules for Diagnosis

TREATMENT OF NEURODEGENERATIVE DISEASES USING ULTRASOUND AND AMYLOID-BETA ANTIBODIES

HUMANIZED CLDN18.2 ANTIBODIES

METHODS AND SYSTEMS FOR TREATING OR PREVENTING PREGNANCY-RELATED HYPERTENSIVE DISORDERS

NUCLEIC ACID ENCODING LILRB1-BASED CHIMERIC ANTIGEN RECEPTOR

ANTI-TCR DELTA VARIABLE 1 ANTIBODIES

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

ANTI-PD-1-ANTI-VEGFA BISPECIFIC ANTIBODY, PHARMACEUTICAL COMPOSITION AND USE THEREOF

ANTI-MUC16 ANTIBODIES AND USES THEREOF

Nucleic acids encoding and methods of producing proteins comprising antibody chains

ANTI-ROR1 ANTIBODIES AND COMPOSITIONS

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

GPC3 BINDING MOLECULES

Chimeric antigen receptors targeting Fc receptor-like 5 and uses thereof

ANTI-CTLA-4 ANTIBODY AND USE THEREOF

MATERIALS AND METHODS FOR POLYMERIC ANTIBODY RECEPTOR TARGETING

Treatment for primary amyloidosis with anti-BCMA binding protein

ANTIBODIES AGAINST SIGNAL-REGULATORY PROTEIN ALPHA AND METHODS OF USE

Bispecific GD2 and B7H3 Binding Molecules and Methods of Use

Anti-PD-1 antibodies and uses thereof

Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and Uses Thereof

Method of Treating Psoriasis in Pediatric Subjects with Anti-IL12/IL23 Antibody

Anti-TIGIT and anti-CD96 antibodies

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO PD-1